Promising Pharma-Free Therapy for Veteran PTSD Families

Promising Pharma-Free Therapy for Veteran PTSD Families

Emotional Freedom Techniques Tap Into Your Own Healing Power

For a How-To-Tap guide, click here.

Emotional Freedom Techniques (EFT), also known as Tapping, is a powerful holistic healing technique. Clinically proven to effectively resolve a range of issues, including PTSD in veteran. Here’s one study where PTSD symptoms were reduced by 50% in a group of veterans.

Once a Soldier supports including EFT as a non-pharma treatmension for veterans and veteran families suffering from PTSD. It is the fast-acting, multi-symptom killer we need right now.

Tapping is a simple technique that uses your own two hands to give you the same benefits experienced by using acupuncture. This blog post will show you how to self-administer EFT.

Tapping therapy is based on the combined principles of ancient Chinese acupressure and modern psychology. Tapping with the fingertips on specific meridian endpoints of the body, while focusing on negative emotions or physical sensations, helps to calm the nervous system, rewire the brain to respond in healthier ways, and restore the body’s balance of energy.

Tapping makes full use of the mind-body connection, acknowledging and integrating the concepts that physical pain, disease, and mental well-being are intricately connected to our emotional states.

The body is equipped with an energy system that travels along pathways known as meridians. Tapping on these meridian endpoints helps to stimulate this system, and when verbally or mentally addressing the root causes of distress, the areas of blocked energy are able to release and flow naturally.

The basic Tapping technique requires you to focus on the negative emotion at hand – a fear, a worry, a bad memory, an unresolved problem, or anything that’s bothering you. While maintaining your mental focus on this issue, you use your fingertips to tap 5-7 times on each of the 9 specific meridian points of the body.

Tapping on these meridian points in sequence while concentrating on the negative emotions engages both the brain’s limbic system and the body’s energy system, encouraging a sense of safety and resolution. And as the scientific field of epigenetics is proving, when you change your internal environment – your emotions and beliefs – external changes in your mental & physical health will follow.

In some ways, Tapping is similar to acupuncture. Like Tapping, acupuncture achieves healing through stimulating the body’s meridians and energy flow. However, unlike Tapping, acupuncture involves needles! “No needles” is definitely one of the advantages of Tapping!

Tapping is simple and painless. It can be learned by anyone, and you can apply it to yourself whenever you want, wherever you are. It can be used with a specific emotional intent towards your own unique life challenges and experiences. Most importantly, Tapping gives you the power to heal yourself, putting control over your destiny back into your own hands.


Veteran families serve just like the soldier, even more so after they’re gone. Our mission is to help them bury their loved ones with honor through our advocacy, financial aid and mental health support.

Our Veterans are killing themselves in record numbers mostly due to PTSD. An overmatched VA can’t take care of them or their families. We will. Soldier suicide leaves Veteran families with thousands of dollars of bills unpaid, mostly bank loans We are the only nonprofit standing with the families after a veteran suicide. Stand with us.

Our Mission: Connect veteran families in need with those who want to help care them.

Once a Soldier Advocates to Rep. Rutherford’s Office

Once a Soldier Advocates to Rep. Rutherford’s Office

Open-Minded & Ready to Help

Once a Soldier advocates on behalf of veteran families touched by veteran suicide. We believe that PTSD is the reason most of our families are faced with the ongoing pain and suffering of vetearn suicide. We see it as a part of our mission to do all we can to make their voices heard.

We recently met with Chris Miller, the District Director for U.S. House of Representative John Rutherford. Mr. Rutherford recently re-introduced the PAWS bill to the House.

For more on the PAWS bill, check this blog post.

Our Agenda 

Chris Miller is ex-military and his tall, slender frame and greying on the sides hair make him the perfect Aide right out of Central Casting. We met at their modest offices in Jacksonville’s mid-town – definitely more functional than flashy. Part of the reason that Once a Soldier was able to get in front of Congressman Rutherford was that his receptionist’s family had suffered from veteran suicide.

We talked about the pain points that families of veteran suicide face:

  • Loss of Insurance Policy
  • Funeral Home Policy
  • PTSD Therapies that Show Promise

Mr. Miller was most interested in the first point that we made. With so many insurance company lobbyists in Washington, D.C., he was courageous indeed to bring the matter up with his Legislative Directors. Our goal was to move the needle on this point: allow a veteran diagnosed with PTSD who has killed himself an exemption from being the insurance being disallowed from the suicide clause. Perhaps not the full amount, but a minimum of $20,000 to cover the funeral expenses.

With the PAWS Act being freshly re-introduced by his office not too long ago, we felt that asking him to take on another Veteran-centric bill would be too much too fast. We have since revisited that idea with an request to consider a bill that fast-tracks pharma and non-parma PTSD therapies.

Next, the realities of the funeral home practices, where payment is traditionally secured by life insurance of the departed, were a surprise to the office. We were happy to get agreement that something could be done to make this a win-win-win for the insurance companies, the funeral business and our families. We are working on that solution as we speak.

Finally, our in-depth and front line access to a local PTSD therapy clinic helped us plead the case for continuing on to push through after the Spravato breakthough. This newly FDA-approved PTSD therapy is a nasal spray that failed to prove itself in the testing phase, but is now being pushed out to VA medical centers. Expensive and cumbersome, this therapy was a good start, but not the future of PTSD therapy. 

We were invited to continue the conversation and we are. Thank you to Chris Miller for his attention and sincerity during and after our visit.


As Sheriff Rutherford Of Jacksonville, He Focused on Mental Health Issues

Sheriff Rutherford


Rutherford, who was director of the jail before being elected sheriff in 2003, is credited with improvements in its ability to address mental health issues. Since he became sheriff, a re-entry program to assist released state prisoners back into society has been established.

In partnership with the city and in the community, programs to ward off criminal activity with prevention and intervention were expanded.

Using tactics such as old-fashioned “knock and talks,” officers stepped onto tens of thousands of doorsteps to meet residents in high-crime neighborhoods.


Our Veterans are killing themselves in record numbers mostly due to PTSD. An overmatched VA can’t take care of them or their families. We will.

Soldier suicide leaves Veteran families with thousands of dollars of bills unpaid, mostly bank loans.

We are the only nonprofit standing with the families after a veteran suicide. Stand with us.

Our Mission: Become the preferred channel for donors, advocates and volunteers who care about veteran families left behind after a soldier suicide.

Spravato is a Good Start But Not The Future of PTSD Treatment

Spravato is a Good Start But Not The Future of PTSD Treatment

After 20 Years of Waiting, Expensive Nasal Spray Fails to Realize Ketamine’s Full Potential

“Spravato is a landmark approval, now we need to accelerate the improvements. And we can’t wait years and years for them while politicians get “comfortable” with the idea of what these drugs can do. The lives of our vets and their PTSD-riddled families need saving now” says Once a Soldier’s CEO David Barbush. “Better in-clinic ketamine drip treatments are out there and they’re the real PTSD-killer.”

Once a Soldier Calls for Fast Track and Breakthrough Therapy Designations for Ketamine Drip Therapy

The difference between the results in the two therapies is measured on a scale called the 60-point Montgomery-Åsberg Rating Scale for Depression. Patients who did the ketamine drip therapy lowered their risk scores by an avearge of 30 points compared to the 5 points in the test. More information on what it’s like in a Ketamine PTSD therapy clinic can be found in this blog.

To illustrate the ill-advised position the FSA has taken with esketamine and Spravato, we will review the FDA’s press release on the day it was approved and counter their language with other facts and observations in bold type.

“In March 06, 2019, the U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting from sedation and dissociation caused by Spravato administration, and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system, under a Risk Evaluation and Mitigation Strategy (REMS).

Ketamine is already being misused as a street drug called Special K. There’s no risk to guard against. Like Spravato’s recommendations, ketamine drip therapy is an in-clinic treatment with a registered and certified nurse attendant who monitors the use and after use. Two weeks with four treatments lowered their suicide score and top-off treatments keep them feeling and staying alive.

“There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition,” said Tiffany Farchione, M.D., acting director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research.

Here, long-standing means that he FDA approved ketamine (Ketalar) in 1970, and now in 2019, is the first time a product has been approved.

The Spravato labeling contains a Boxed Warning that cautions that patients are at risk for sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, and suicidal thoughts and behaviors after administration of the drug.

In fact, three patients in their 20-person test group still killed themselves. Somehow, the results for Spravato only got worse before it got approved:

The efficacy of Spravato was evaluated in three short-term (four-week) clinical trials and one longer-term maintenance-of-effect trial. In the three short-term studies, patients were randomized to receive Spravato or a placebo nasal spray.

This is another way of explaining the poor results in perspective:

Spravato, a single four-week placebo-controlled trial showed a 4-point improvement on the 60-point Montgomery-Åsberg Rating Scale for Depression. While this met the criteria for statistical significance, a 4-point difference is likely too paltry to be noticeable in a face-to-face assessment of global functioning by a trained clinician.

The results of the two other placebo-controlled trials of Spravato were negative. The only way to satisfy the FDA requirement for two positive trials was to count the results of a relapse study, which essentially showed that patients who did well on the drug, did well on the drug.


A one-month testing period? Cialis and Viagra underwent an almost decade long study. 


In light of the serious nature of treatment-resistant depression and the need for patients to receive some form of treatment, all patients in these studies started a new oral antidepressant at the time of randomization and the new antidepressant was continued throughout the trials.

Patients were on other depression drugs that may have been responsible for the tepid results.

The primary efficacy measure was the change from baseline on a scale used to assess the severity of depressive symptoms. In one of the short-term studies, Spravato nasal spray demonstrated statistically significant effect compared to placebo on the severity of depression, and some effect was seen within two days.

Ketamine drip therapy not only lowers their likelihood of suicide, but they felt better the same day as their visit. 

The two other short-term trials did not meet the pre-specified statistical tests for demonstrating effectiveness. In the longer-term maintenance-of-effect trial, patients in stable remission or with stable response who continued treatment with Spravato plus an oral antidepressant experienced a statistically significantly longer time to relapse of depressive symptoms than patients on placebo nasal spray plus an oral antidepressant.

In other words, of the three tests, it failed two of them and the only way to get FDA approval was by a follow up report on the “successful” test. 


High Price to Pay for Mixed Results

Johnson & Johnson said it was working to educate and certify treatment centers for Spravato. J&J priced the drug at a wholesale acquisition cost of $590 to $885 per treatment session, depending on which dose patients receive.

During the one-month induction phase, treatment with Spravato would cost between $4,720 to $6,785. If a patient responds, dosing would change in the maintenance phase, putting the subsequent monthly list price for the drug between $2,360 and $3,540.

In an emailed statement, J&J said Spravato’s list price is “generally comparable” with other specialty mental health drugs.


Our Veterans are killing themselves in record numbers mostly due to PTSD. An overmatched VA can’t take care of them or their families. We will.

Soldier suicide leaves Veteran families with thousands of dollars of bills unpaid, mostly bank loans.

We are the only nonprofit standing with the families after a veteran suicide. Stand with us.

Our Mission: Become the preferred channel for donors, advocates and volunteers who care about veteran families left behind after a soldier suicide.

The Promise of Ketamine for PTSD

The Promise of Ketamine for PTSD

Step Inside a Veteran-Run Ketamine IV Drip PTSD Therapy Clinic

The future for PTSD treatment looks bright – so let’s get right to it. Our focus will be on the drug ketamine and how micro-dosing with certified and trained professionals is a promising PTSD-killer.

Ketamine is an anesthetic used in every OR in the world. Low doses given via IV are showing fast-acting and lasting results for suicidal and depressed veterans. 

Other non-pharmaceutical drugs like marijuana and magic mushrooms are also showing great promise, but until there are some big changes in the stigmas and Schedule 1 classifications defining them, ketamine will probably be the first game-changer to hit the mass market. In fact, thanks to the Food and Drug Administration (FDA) approving it as a prescription treatment for depression in May 2019, it’s already out there.

Check this blog post for a timeline of the latest treatments.

A Wealth of Research Riches

Ketamine PTSD Clinical Research Data Sources

From Google Scholar – a library of links to clinical trials papers


Lawmakers and PTSD Therapy – An Unlikely Meeting Place

On Capitol Hill, the plight of veterans suffering from PTSD who are killing themselves is getting more attention than ever. Trying to solve the puzzle of PTSD and veteran suicide enjoys bi-partisan support from legislators as diverse as Rep. Alexandria Ocasio-Cortez (D-NY) and Rep. John Rutherford (R-FL) who served a decade at the head of the as the Jacksonville Sheriff’s Office. Common ground is akin to Holy ground these days in Congress, so this is real progress.

Short History of PTSD Therapy

Before we move forward, let’s take a step back with some historical context:

Ketamine came off patent in 1960, meaning that just like how music and movies enter into the public domain, anyone can make their version of and make money from it.

In March 2019, after many clinical trials like this one from 2014 by the Mayo Clinic, the FDA approved a ketamine nasal spray for those who are classified with treatment-resistant depression. This spray is marketed under the name of Spravato and made by Johnson & Johnson. Both promising and falling short on that promise, the drug hasn’t outperformed the placebo.

As you’ll see, the reason is because the spray only uses half the molecule. PTSD micro-dosing via IV beats the spray in results and it is our position that lawmakers need to revise the old laws that are out of touch with today’s medical advancements.

Brian Hogan, Director at Sunbelt Wellness Clinic

Brian Hogan, Director at Sunbelt Wellness Institute, is on the front lines of ketamine-infused PTSD therapy. As a Navy veteran himself, Mr. Hogan’s heart and mind are in the right place for this big challenge.

OAS: What is it about the spray, Spravato, that could be better?
Brian Hogan: It’s a great start and we’re happy to see the FDA’s approval of it. It really is going to open up a lot of doors for people suffering with PTSD and those veterans killing themselves over it.

On the downside, like you said, it’s just as effective as the placebo, so that could be better. One of the reasons it that Spravato is the ketamine molecule chopped in half. While this will reduce side effects, it also limits effectiveness. Ketamine is the whole molecule. This increase hasn’t impacted the side effects. We haven’t seen the anxiety during a treatment that was predicted.

Second, the price is approximately $7,500 for initial treatments. That’s just for the medication, not including monitoring and in time in a facility. We’re about half that cost.

PTSD Treatments

OAS: Okay, tell me about the treatments.

Brian Hogan: First off, the micro-dosing has shown to be non-addictive, unlike opioids. And there’s only 6 treatments required for most patients to test low and stay low on the PCL5 scale of “how depressed are you?”

We administer the drip in a regular IV bag. The ketamine is mixed with saline, it’s delivered through a pump, and the infusion lasts about 40 minutes. The experience for the patient is that they’re sitting in a reclining easy chair listening to music on headphones with a registered and certified nurse, in our case all Navy-trained veterans, by their side.

These micro-doses also don’t sedate patient. They’re easily aroused from whatever state of mind they’re back to the here and now.

OAS: Can you describe the patient’s state of mind during the session and how it actually helps them deal with their PTSD?
Brian Hogan: This is the interesting part and why there’s so much attention on the results. To start with, the medication plays with their mind in terms of the passage of time. To them, their forty-minute sessions seems to have passed in just five minutes.

How they deal with their PTSD has been described as a three-part meeting between them, their memory of the experiences, and a distance between the two that gives them the new perspective they’ve needed. This feeling of being out of their body enables them to feel safe as they deal with the problems.

For some, PTSD is described as a negative thought that comes in and just sits there. Then poof, it’s turned into a cloud and is gone. Pretty mind blowing.

 Ketamine Drips are Fast-Acting and Lasting Relief

OAS: I read about fast-acting results, but what have you seen in your clinic working with the veterans?
Brian Hogan: The clinical term for these kinds of drugs is Rapidly Acting Antidepressants, or RADS. Ketamine falls into this category. In our practice, they have tested out with same-day results that we’re overjoyed with. As are our veterans.

If the patient comes in with suicidality, they get an immediate ketamine infusion and it works. Most patients report a 70% lift two hours after their treatment.

OAS: Can you provide us with some of the data behind that?
Brian Hogan: The way that depression is measured is via something called a DCM5 checklist. It has 20 itemized questions that ask about feelings of depression and suicide. They are then transformed into a number scale from the National Center for PTSD to give us a guide, called the PCL5 scale that lets us know how severe their depression is.

PTSD-infused has shown a 33.3 reduction on scales using PCL5 scale. That’s a significant reduction.

In anecdotal terms, our patients have reported that after the very first treatment, 70% of our patients feel better, after the second treatment feel 85% feel better, and after the third treatment, they level off or rise up a small amount.

OAS: How long are they one this drug and how long is each session?
Brian Hogan: Our initial consultation lasts about 30 minutes. Treatments last 40 minutes. During that time, patients are accompanied by one of our certified registered nurse aestheticians who administer the IV and monitor the session.

OAS: Micro-dosing is a new term in the vocabulary of PTSD treatments. What does that mean for ketamine?
Brian Hogan: Most of the staff here are veterans and work in our community’s medical centers in surgery centers and ORs. Micro-dosing for us translates into using 1,000 less of a dose than you would get for anesthesia for surgery. To be more precise, our vets receive a range of .5 -.7mg over a 40 minute session. That’s a micro-dose.

OAS: People know some of the more popular depression drugs like Zoloft, Prozac and Paxil. How is ketamine different from them?
Brian Hogan: If you’re clinically depressed, you get put on a class of medications called Serotonergic anti-depressions (SSRI). For most of the patients, two-thirds of them, one of those you listed, or the other five or so you didn’t list, will give them meaningful results.

If you don’t respond to those drugs, you are what we call “depression drug resistant.” Now it’s time to try the pMDMA receptors

Keta plays on the glutamate pathway. It’s a different neural pathway taken but for some people, it’s the one that gives them relief.

Next time we’ll speak with some of the patients of Sunbelt Wellness Clinic and hear from them their results and what it’s like to micro-dose and confront your worst fears.

Additional Research re: Ketamine + PTSD Sources

From Google Scholar – a library of links to clinical trials papers



Our Veterans are killing themselves in record numbers mostly due to PTSD. An overmatched VA can’t take care of them or their families. We will.

Soldier suicide leaves Veteran families with thousands of dollars of bills unpaid, mostly bank loans.

We are the only nonprofit standing with the families after a veteran suicide. Stand with us.

Our Mission: Become the preferred channel for donors, advocates and volunteers who care about veteran families left behind after a soldier suicide.

PAWS Act and the VA

PAWS Act and the VA

Congressional Bill Seeks Financial Help for Service Dog PTSD Therapy

Service animals have become widely accepted to assist those with diabetes, seizures, autism and allergies. We’ve seen support animals on shopping trips, in our places of work and even on planes. Although the type and expectations of these animals has been debated, one accepted fact is that the connection with and assistance of a service dog can enhance and preserve the life of a veteran living with PTSD. With restaurants, airlines, and various military organization’s acceptance of these valuable companions, why hasn’t the VA gotten on board?

The PAWS Act was introduced in 2016 by Florida Representative Ron DiSantis, now Governor,  and the CEO of K9s for Warriors, a Florida-based canine service provider. The VA did not endorse the bill. It was not passed and now in 2019, another Florida Congressman, John Rutherford, reintroduced it. 

Before 2015 the VA did not have any formal regulation that ensured consistent practices on allowance of service dogs on VA owned or leased property. Until new regulation was created, the use of service animals on VA campuses was left to the discretion of each individual campus. These obscure policies most likely deterred veterans using service animals from seeking important services and the VA’s lack of support for service dogs continues to prevent soldiers from the life saving assistance of these respected companions.

The Puppies Assisting Wounded Service Members (PAWS) Act is pushing for the VA to not only acknowledge and accept the power of these canine companions, but to offer financial assistance for this form of therapy as it does with other PTSD treatments. The PAWS act would require the Department of Veterans Affairs to issue grants to nonprofits that provide service dogs. These funds would cover veterinary costs, hardware required to perform tasks, and travel expenses to obtain a dog.

While the VA currently provides veterinary care assistance for service dogs that assist those with physical disabilities, it does not currently provide service dogs for physical or mental conditions. This is why the work of important nonprofits like K9s For Warriors have worked to provide these lifesaving companions for post 9/11 veterans affected by Post-traumatic Stress Disorder, Traumatic Brain Injury or sexual trauma as a result of service. Organizations must meet eligibility requirements in order to receive grant funds.

Contact your local representative to let them know that you believe in the power of companionship, and that you demand that the VA provides the resources that our soldiers deserve. For some, having a comrade to help navigate life can mean the difference between life and death.


Our Veterans are killing themselves in record numbers mostly due to PTSD. An overmatched VA can’t take care of them or their families. We will.

Soldier suicide leaves Veteran families with thousands of dollars of bills unpaid, mostly bank loans.

We are the only nonprofit standing with the families after a veteran suicide. Stand with us.

Our Mission: Become the preferred channel for donors, advocates and volunteers who care about veteran families left behind after a soldier suicide.

VA Not High on Medical Marijuana as PTSD Treatment for Veterans

VA Not High on Medical Marijuana as PTSD Treatment for Veterans

Veteran Administration’s Position Hurts Veterans Suffering From PTSD

At Once A Soldier, our dedicated team understands the detrimental and debilitating impact that PTSD can have on soldiers, veterans, and their families. This is why we support a variety of local and federal initiatives that aim to support veterans and their families as they cope with the crippling effects of PTSD. Among the initiatives supported by Once A Soldier are those related to the legalization of marijuana for medicinal purposes. However, despite the fact that marijuana has been proven to have positive effects on soldiers and veterans suffering from PTSD, legislation that allows marijuana to have a role at the VA will not be supported.

At Once A Soldier, we believe that anything clearly proven to help soldiers and veterans cope with their trauma should be supported by the VA. As our CEO and Chairman, Dave Barbush states, “The Veterans Administration was right in deferring to US law, but needed to go the extra step for Veterans, something they’ve proven they’re incapable of.”


Veteran families of soldier suicide tells us that, after a suicide, that the actual suicide becomes the least of their problems. Money and the business of death become their enemy.

VA Refuses to Modernize

Lack of Education Is Killing Our Veterans


This recent announcement by the VA is disappointing to our team at Once A Soldier, as there have been numerous studies proving marijuana’s effectiveness in alleviating PTSD symptoms. As local governments across the nation deem marijuana fit for medical and recreational use, researchers have been able to study its effects in more detail than ever before. Much of this research has found that, by balancing the various chemical compounds found in marijuana, the plant can be used to effectively treat common ailments such as anxiety, insomnia and pain. Because of this, medical marijuana has been proven to be highly effective when treating those diagnosed with PTSD, many of whom are soldiers and veterans.

Typically, Post Traumatic Stress Disorder, commonly referred to as PTSD, develops after an individual experiences a traumatic or life-altering event, such as serving in combat or being on active duty. PTSD can lead to chronic nightmares, flashbacks, and cause difficulty sleeping and functioning normally in daily life. PTSD can often be so severe that an individual’s overall emotional state and perception of the world around them can be damaged forever.

Marijuana is capable of alleviating some of these harmful symptoms because of two main components found in the plant: tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is responsible for binding to specific receptors in the brain that regulate mood, sleep patterns, and perceptions of pain. Many scientists also believe that THC interacts with the amygdala and hippocampus (the brain’s main emotional centers) to help reduce anxiety.

CBD, on the other hand, is not as widely understood due to its complexity, however researchers do understand it’s influence on the body’s endocannabinoid system. The endocannabinoid system is responsible for maintaining the body’s emotional homeostasis, as well as regulating memory consolidation, retrieval and extension. CBD improves the endocannabinoid system’s mediation of essential functions, including memory consolidation and retrieval. When CB1 and CB2 receptors located throughout this core system are activated, cannabinoids can prompt the system to produce neurotransmitters that promote happiness, pleasure, and memory. These specific cannabinoids play an important role in assisting veterans suffering from PTSD by preventing the brain from retrieving the underlying trauma, effectively preventing traumatic memories and nightmares, while also helping the individual attain an overall state of emotional wellbeing.

There are currently three bills in front of the House Veterans Affairs Health Subcommittee that relate to medical marijuana access for veterans. One, the Veterans Equal Access Act, H.R. 1647, sponsored by Rep. Earl Blumenauer, D-Oregon, would allow VA health providers to recommend medical marijuana to their veteran patients and fill out the necessary paperwork for them to enroll in state marijuana programs. However, the VA responded to these efforts with the following statement:

“[The House Veterans Affairs Committee] can make strong proposals for us to move forward with recommendations of filling out forms and such but, in the end, we need to go back to the [Drug Enforcement Agency] and [Justice Department] for their opinion,” – Larry Mole, chief consultant for population health at the VA.

If you are interested in supporting Once A Soldier’s mission to provide financial assistance to families of veterans who have committed suicide due to the unfortunate effects of PTSD, please donate to our cause today.

Once a Soldier Mission: Become the preferred channel for donors, advocates and volunteers who care about veteran families left behind after a soldier suicide. Financial and emotional support are offered to those families that demonstrate the need. Our Veterans are killing themselves in record numbers mostly due to PTSD. An overmatched VA can’t take care of them or their families. We will. Soldier suicide leaves Veteran families with thousands of dollars of bills unpaid, mostly bank loans. Learn more about our impact here.

Wrist Bands in Memory of Jared Johns

jarod johns wristband


Lost on 9/11/2018, Jared Johns left behind a family who loved him and then some. Please support us and him. Click this link to help.